A Fra-1-dependent, matrix metalloproteinase driven EGFR activation promotes human lung epithelial cell motility and invasion

Journal of Cellular Physiology

Volumn 216, Issue 2, 2008, Pages 405-412

  Adiseshaiah, Pavan ^a,d   Vaz, Michelle ^a   Machireddy, Narsa ^a   Kalvakolanu, Dhananjaya V ^c   Reddy, Sekhar P ^a,b,e  

^a The Johns Hopkins University   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^d Avalon Pharmaceuticals   (United States)

^e JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE; TRANSCRIPTION FACTOR FRA 1;

ARTICLE; CELL ACTIVATION; CELL INVASION; CELL MOTILITY; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; LUNG ALVEOLUS EPITHELIUM; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION;

CARCINOGENS; CELL LINE, TUMOR; CELL MOVEMENT; ENZYME ACTIVATION; ENZYME INHIBITORS; EPITHELIAL CELLS; HUMANS; LUNG NEOPLASMS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; PHENOTYPE; PROTO-ONCOGENE PROTEINS C-FOS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

EID: 46049117511     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21410     Document Type: Article

References (41)

1. Adiseshaiah P, Papaiahgari SR, Vuong H, Kalvakolanu DV, Reddy SP. 2003. Multiple cis-Elements Mediate the Transcriptional Activation of Human fra-1 by 12-O-Tetradecanoylphorbol-13-acetate in Bronchial Epithelial Cells. J Biol Chem 278:47423-47433.
2. Adiseshaiah P, Peddakama S, Zhang Q, Kalvakolanu DV, Reddy SP. 2005. Mitogen regulated induction of FRA-1 proto-oncogene is controlled by the transcription factors binding to both serum and TPA response elements. Oncogene 24:4193-4120.
3. Adiseshaiah P, Lindner DJ, Kalvakolanu DV, Reddy SP. 2007. FRA-1 proto-oncogene induces lung epithelial cell invasion and anchorage-independent growth in vitro, but is insufficient to promote tumor growth in vivo. Cancer Res 67:6204-6211.
4. Belguise K, Kersual N, Galtier F, Chalbos D. 2005. FRA-1 expression level regulates proliferation and invasiveness of breast cancer cells. Oncogene 24:1434-1444.
5. Benbow U, Brinckerhoff CE. 1997. The AP-1 site and MMP gene regulation: what is all the fuss about? Matrix Biol 15:519-526.
6. Bergman MR, Cheng S, Honbo N, Piacentini L, Karliner JS, Lovett DH. 2003. A functional activating protein 1 (AP-1) site regulates matrix metalloproteinase 2 (MMP-2) transcription by cardiac cells through interactions with JunB-Fra1 and JunB-FosB heterodimers. Biochem J 369:485-496.
7. Chakraborti S, Mandal M, Das S, Mandal A, Chakraborti T. 2003. Regulation of matrix metalloproteinases: An overview. Mol Cell Biochem 253:269-285.
8. Chetty C, Bhoopathi P, Joseph P, Chittivelu S, Rao JS, Lakka S. 2006. Adenovirus-mediated small interfering RNA against matrix metalloproteinase-2 suppresses tumor growth and lung metastasis in mice. Mol Cancer Ther 5:2289-2299.
9. Coussens LM, Fingleton B, Matrisian LM. 2002. Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science 295:2387-2392.
10. Eferl R, Wagner EF. 2003. AP-1: A double-edged sword in tumorigenesis. Nat Rev Cancer 3:859-868.
11. Festuccia C, Angelucci A, Gravina GL, Biordi L, Millimaggi D, Muzi P, Vicentini C, Bologna M. 2005. Epidermal growth factor modulates prostate cancer cell invasiveness regulating urokinase-type plasminogen activator activity. EGF-receptor inhibition may prevent tumor cell dissemination. Thromb Haemost 93:964-975.
12. Fischer OM, Hart S, Gschwind A, Ullrich A. 2003. EGFR signal transactivation in cancer cells. Biochem Soc Trans 31:1203-1208.
13. Franklin WA, Veve R, Hirsch FR, Helfrich BA, Bunn PA, Jr. 2002. Epidermal growth factor receptor family in lung cancer and premalignancy. Semin Oncol 29:3-14.
14. Gouyer V, Conti M, Devos P, Zerimech F, Copin MC, Creme E, Wurtz A, Porte H, Huet G. 2005. Tissue inhibitor of metalloproteinase 1 is an independent predictor of prognosis in patients with nonsmall cell lung carcinoma who undergo resection with curative intent. Cancer 103:1676-1684.
15. Guo W, Giancotti FG. 2004. Integrin signalling during tumour progression. Nat Rev Mol Cell Biol 5:816-826.
16. Hirama N, Shibata Y, Otake K, Machiya J, Wada T, Inoue S, Abe S, Takabatake N, Sata M, Kubota I. 2007. Increased surfactant protein-D and foamy macrophages in smoking-induced mouse emphysema. Respirology 12:191-201.
17. Hiratsuka S, Nakamura K, Iwai S, Murakami M, Itoh T, Kijima H, Shipley JM, Senior RM, Shibuya M. 2002. MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis. Cancer Cell 2:289-300.
18. Hong S, Park KK, Magae J, Ando K, Lee TS, Kwon TK, Kwak JY, Kim CH, Chang YC. 2005. Ascochlorin inhibits matrix metalloproteinase-9 expression by suppressing activator protein-1-mediated gene expression through the ERK1/2 signaling pathway. Inhibitory effects of ascochlorin on the invasion of renal carcinoma cells. J Biol Chem 280:25202-25209.
19. Hrabec E, Strek M, Nowak D, Greger J, Suwalski M, Hrabec Z. 2002. Activity of type IV collagenases (MMP-2 and MMP-9) in primary pulmonary carcinomas: A quantitative analysis. J Cancer Res Clin Oncol 128:197-204.
20. Itoh T, Tanioka M, Matsuda H, Nishimoto H, Yoshioka T, Suzuki R, Uehira M. 1999. Experimental metastasis is suppressed in MMP-9-deficient mice. Clin Exp Metastasis 17:177-181.
21. Kustikova O, Kramerov D, Grigorian M, Berezin V, Bock E, Lukanidin E, Tulchinsky E. 1998. Fra-1 induces morphological transformation and increases in vitro invasiveness and motility of epithelioid adenocarcinoma cells. Mol Cell Biol 18:7095-7105.
22. Lieber M, Smith B, Szakal A, Nelson-Rees W, Todaro G. 1976. A continuous tumor-cell line from a human lung carcinoma with properties of type II alveolar epithelial cells. Int J Cancer 17:62-70.
23. Lin TS, Chiou SH, Wang LS, Huang HH, Chiang SF, Shih AY, Chen YL, Chen CY, Hsu CP, Hsu NY, Chou MC, Kuo SJ, Chow KC. 2004. Expression spectra of matrix metalloproteinases in metastatic non-small cell lung cancer. Oncol Rep 12:717-723.
24. Lu Z, Jiang G, Blume-Jensen P, Hunter T. 2001. Epidermal growth factor-induced tumor cell invasion and metastasis initiated by dephosphorylation and down regulation of focal adhesion kinase. Mol Cell Biol 21:4016-4031.
25. Park SI, Shah AN, Zhang J, Gallick GE. 2007. Regulation of angiogenesis and vascular permeability by Src family kinases: Opportunities for therapeutic treatment of solid tumors. Expert Opin Ther Targets 11:1207-1217.
26. Pollock CB, Shirasawa S, Sasazuki T, Kolch W, Dhillon AS. 2005. Oncogenic K-RAS is required to maintain changes in cytoskeletal organization, adhesion, and motility in colon cancer cells. Cancer Res 65:1244-1250.
27. Ramos-Nino ME, Timblin CR, Mossman BT. 2002. Mesothelial cell transformation requires increased AP-1 binding activity and ERK-dependent Fra-1 expression. Cancer Res 62:6065-6069.
28. Ramos-Nino ME, Scapoli L, Martinelli M, Land S, Mossman BT. 2003. Microarray Analysis and RNA Silencing Link fra-1 to cd44 and c-met Expression in Mesothelioma. Cancer Res 63:3539-3545.
29. Rao JS, Gondi C, Chetty C, Chittivelu S, Joseph PA, Lakka SS. 2005. Inhibition of invasion, angiogenesis, tumor growth, and metastasis by adenovirus-mediated transfer of antisense uPAR and MMP-9 in non-small cell lung cancer cells. Mol Cancer Ther 4:1399-1408.
30. Scapoli L, Ramos-Nino ME, Martinelli M, Mossman BT. 2004. Src-dependent ERK5 and Src/EGFR-dependent ERK1/2 activation is required for cell proliferation by asbestos. Oncogene 23:805-813.
31. Sekido Y, Fong KM, Minna JD. 2003. Molecular genetics of lung cancer. Annu Rev Med 54:73-87.
32. Summy JM, Gallick GE. 2003. Src family kinases in tumor progression and metastasis. Cancer Metastasis Rev 22:337-358.
33. Tower GB, Coon CI, Belguise K, Chalbos D, Brinckerhoff CE. 2003. Fra-1 targets the AP-1 site/2G single nucleotide polymorphism (ETS site) in the MMP-1 promoter. Eur J Biochem 270:4216-4225.
34. Vial E, Sahai E, Marshall CJ. 2003. ERK-MAPK signaling coordinately regulates activity of Rac1 and RhoA for tumor cell motility. Cancer Cell 4:67-79.
35. Wistuba II, Mao L, Gazdar AF. 2002. Smoking molecular damage in bronchial epithelium. Oncogene 21:7298-7306.
36. Xue C, Wyckoff J, Liang F, Sidani M, Violini S, Tsai KL, Zhang ZY, Sahai E, Condeelis J, Segall JE. 2006. Epidermal growth factor receptor overexpression results in increased tumor cell motility in vivo coordinately with enhanced intravasation and metastasis. Cancer Res 66:192-197.
37. Yamamura T, Nakanishi K, Hiroi S, Kumaki F, Sato H, Aida S, Kawai T. 2002. Expression of membrane-type-1-matrix metalloproteinase and metalloproteinase-2 in nonsmall cell lung carcinomas. Lung Cancer 35:249-255.
38. Zhang M, Singh RK, Wang MH, Wells A, Siegal GP. 1996. Epidermal growth factor modulates cell attachment to hyaluronic acid by the cell surface glycoprotein CD44. Clin Exp Metastasis 14:268-276.
39. Zhang Q, Kleeberger SR, Reddy SP. 2004. DEP-induced fra-1 expression correlates with a distinct activation of AP-1-dependent gene transcription in the lung. Am J Physiol Lung Cell Mol Physiol 286:L427-436.
40. Zhang Q, Adiseshaiah P, Reddy SP. 2005. Matrix metalloproteinase/ epidermal growth factor receptor/mitogen-activated protein kinase signaling regulate fra-1 induction by cigarette smoke in lung epithelial cells. Am J Respir Cell Mol Biol 32:72-81.
41. Zhang Q, Adiseshaiah P, Kalvakolanu DV, Reddy SP. 2006. A phosphatidylinositol 3-kinase regulated Akt independent signaling promotes cigarette smoke induced FRA-1 expression. J Biol Chem 281:10174-10181.